β-agonist intrinsic efficacy -: Measurement and clinical significance

被引:80
作者
Hanania, NA
Sharfkhaneh, A
Barber, R
Dickey, BF
机构
[1] Baylor Coll Med, Dept Med, Pulm & Crit Care Med Sect, Houston, TX 77030 USA
[2] Vet Adm Med Ctr, Houston, TX 77211 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Integrat Biol Pharmacol & Physiol, Houston, TX USA
关键词
D O I
10.1164/rccm.2109060
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
[No abstract available]
引用
收藏
页码:1353 / 1358
页数:6
相关论文
共 51 条
  • [1] BETA-ADRENERGIC RECEPTORS AND THEIR REGULATION
    BARNES, PJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) : 838 - 860
  • [2] A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler
    Bensch, G
    Lapidus, RJ
    Levine, BE
    Lumry, W
    Yegen, Ü
    Kiselev, P
    Della Cioppa, G
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2001, 86 (01) : 19 - 27
  • [3] Partial vs full beta-receptor agonism - A clinical study of inhaled albuterol and fenoterol
    Bremner, P
    Siebers, R
    Crane, J
    Beasley, R
    Burgess, C
    [J]. CHEST, 1996, 109 (04) : 957 - 962
  • [4] A comparison of the efficacy of long-acting β2-agonists:: eformoterol via Turbohaler® and salmeterol via pressurized metered dose inhaler or Accuhaler®, in mild to moderate asthmatics
    Campbell, LM
    Anderson, TJ
    Parashchak, MR
    Burke, CM
    Watson, SA
    Turbitt, ML
    [J]. RESPIRATORY MEDICINE, 1999, 93 (04) : 236 - 244
  • [5] Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia
    Cazzola, M
    Imperatore, F
    Salzillo, A
    Di Perna, F
    Calderaro, F
    Imperatore, A
    Matera, MG
    [J]. CHEST, 1998, 114 (02) : 411 - 415
  • [6] LONG-TERM EFFECTS OF A LONG-ACTING BETA-2-ADRENOCEPTOR AGONIST, SALMETEROL, ON AIRWAY HYPERRESPONSIVENESS IN PATIENTS WITH MILD ASTHMA
    CHEUNG, D
    TIMMERS, MC
    ZWINDERMAN, AH
    BEL, EH
    DIJKMAN, JH
    STERK, PJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (17) : 1198 - 1203
  • [7] Partial agonists and G protein-coupled receptor desensitization
    Clark, RB
    Knoll, BJ
    Barber, R
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (07) : 279 - 286
  • [8] Comparison of the efficacy of formoterol and salmeterol in patients with reversible obstructive airway disease: A multicenter, randomized, open-label trial
    Condemi, JJ
    [J]. CLINICAL THERAPEUTICS, 2001, 23 (09) : 1529 - 1541
  • [9] In patients with COPD, treatment with a combination of formoterol and ipratropium is more effective than a combination of salbutamol and ipratropium - A 3-week, randomized, double-blind, within-patient, multicenter study
    D'Urzo, AD
    De Salvo, MC
    Ramirez-Rivera, A
    Almeida, J
    Sichletidis, L
    Rapatz, G
    Kottakis, J
    [J]. CHEST, 2001, 119 (05) : 1347 - 1356
  • [10] SALMETEROL XINAFOATE AS MAINTENANCE THERAPY COMPARED WITH ALBUTEROL IN PATIENTS WITH ASTHMA
    DALONZO, GE
    NATHAN, RA
    HENOCHOWICZ, S
    MORRIS, RJ
    RATNER, P
    RENNARD, SI
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (18): : 1412 - 1416